Page last updated: 2024-08-22

n-methylaspartate and Cortical Lewy Body Disease

n-methylaspartate has been researched along with Cortical Lewy Body Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, S; Farlow, MR; Hake, AM; Sabbagh, MN1
Christensen, MD; White, HK1

Reviews

1 review(s) available for n-methylaspartate and Cortical Lewy Body Disease

ArticleYear
Dementia assessment and management.
    Journal of the American Medical Directors Association, 2007, Volume: 8, Issue:3 Suppl 2

    Topics: Activities of Daily Living; Advance Care Planning; Aged; Aged, 80 and over; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Dementia; Dementia, Vascular; Humans; Lewy Body Disease; Long-Term Care; Medical History Taking; Middle Aged; N-Methylaspartate; Neurologic Examination; Nutrition Therapy; Physical Examination; Practice Guidelines as Topic; Safety; Social Support

2007

Other Studies

1 other study(ies) available for n-methylaspartate and Cortical Lewy Body Disease

ArticleYear
The use of memantine in dementia with Lewy bodies.
    Journal of Alzheimer's disease : JAD, 2005, Volume: 7, Issue:4

    Topics: Aged; Aged, 80 and over; Dopamine Agents; Female; Humans; Lewy Body Disease; Male; Memantine; N-Methylaspartate; Prospective Studies

2005